PT UBC Medical Indonesia Tbk

The company maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.31, indicating a conservative leverage position. However, its liquidity position is assessed as medium, with a current ratio of 1.94, suggesting the company has sufficient short-term assets to cover its liabilities, but not with a large buffer. The company reported negative net cash, as operating cash flow was -9,276,646,290 IDR, while free cash flow was 3,238,761,210 IDR. This suggests that capital expenditures, which amounted to -3,180,165,240 IDR, were partially offset by positive free cash flow. Profitability metrics are not explicitly provided, but the company's capital structure and liquidity position suggest a relatively stable financial foundation. The debt-to-equity ratio of 0.31 is below the industry median, indicating a lower reliance on debt financing compared to peers. The company's free cash flow generation, despite negative operating cash flow, suggests that it is managing its capital expenditures effectively. The company's geographic exposure is concentrated in Indonesia, as it is a domestic player in the medical equipment and supplies market. There is no indication of significant international operations or revenue diversification. The company's revenue concentration in a single country may expose it to local economic and regulatory risks. The company's growth trajectory is not explicitly outlined in the available data, but the negative operating cash flow and capital expenditures suggest that it may be investing in expansion or modernization. The free cash flow of 3,238,761,210 IDR indicates that the company is generating some cash from operations, which could support future growth initiatives. The company's risk profile includes a medium liquidity risk, as it has a current ratio of 1.94, which is sufficient but not robust. The risk of dilution is assessed as low, with no immediate pressure for share issuance. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.31, which reduces the risk of financial distress. Recent events and filings do not provide specific details on the company's strategic initiatives or financial performance beyond the disclosed financials. The company's 10-K or equivalent filings would provide more detailed insights into its operations and risk factors.